Skip to main content
. 2008 May;4(5):337–347.

Table 6.

Cyclosporine Drug Interactions

Drug Potentiate Renal Dysfunction ↑ Cyclosporine Levels ↓ Cyclosporine Levels Other Interactions
Cyclosporine Antibiotics: ciprofloxacin gentamicin tobramycin vancomycin trimethoprim/sulfamethoxazole
Antineoplastic: melphalan
Antifungals: amphotericin B ketoconazole
Anti-inflammatory drugs: azapropazone colchicine diclofenac naproxen sulindac
Histamine-2 blockers: cimetidine ranitidine
Immunosuppressant: tacrolimus
Fibric acid derivative: fenofibrate
Calcium channel blockers: diltiazem nicardipine verapamil
Antifungals: fluconazole itraconazole ketoconazole
Antibiotics: azithromycin clarithromycin erythromycin quinupristin/dalfopristin
Glucocorticosteroid: methylprednisolone
Protease inhibitors: indinavir nelfinavir ritonavir saquinavir
Other drugs: allopurinol amiodarone bromocriptine colchicine danazol imatinib metoclopramide oral contraceptives
Food: grapefruit juice increases absorption
Antibiotics: nafcillin rifampin
Anticonvulsants: carbamazepine phenobarbital phenytoin
St. John's Wort: decreases serum concentrations of cyclosporine, resulting in subtherapeutic levels
Other drugs: octreotide orlistat sulfinpyrazone terbinafine ticlopidine
Rifabutin: increases the metabolism of drugs metabolized by the cytochrome P-450 system
Diclofenac: doubling of blood levels and (reversible) decrease in renal function
Methotrexate: concentrations were increased 30% and the concentrations of its metabolite, 7-hydroxy methotrexate, were decreased by approximately 80%. The clinical significance is not known.
Decreased clearance of: digoxin colchicines prednisolone 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors (eg, simvastatin, lovastatin)
Potentiate hyperkalemia with: potassium-sparing diuretics angiotensin-converting enzyme inhibitors angiotensin II receptor blockers